BioSpace News Archive

Lannett Company, Inc. announced that it has entered into an agreement with Areva Pharmaceuticals to be the exclusive U.S. distributor of Fludarabine Phosphate for injection, USP, 50 mg/2mL, single dose vials.

Aravive, Inc., a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, reported financial results for the first quarter ended March 31, 2022 and provided corporate updates.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, reported its first quarter 2022 operating and financial results.

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended March 31, 2022, and provided operational updates.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the first quarter ended on March 31, 2022.

Lantern Pharma Inc. (NASDAQ: LTRN ), a clinical stage biopharmaceutical company using its proprietary RADR ® artificial intelligence (“A.I.”) and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that it will host a virtual key opinion leader (KOL) webinar on May 26th, 2022 at 12:00 p.m. ET.

Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the first quarter ended March 31, 2022.

Podimetrics , creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced four new leadership hires aimed at helping the company scale and support even more health plans and providers.

According to the business intelligence study, the global big data in healthcare market is set to grow, featuring a significant growth rate of 19.1 % over the forecast period i.e. 2018 to 2025.

DUBAI, United Arab Emirates, In addition to the fact that sizeable population with a sleep disorder remains undiagnosed, increasing awareness about the availability of screening and diagnostic methods will push the sales of sleep apnea diagnostic system sales over the following years.